Inflation Reduction Act Backfires! Paralyzing Our Drug Industry
Former FDA Commissioner Scott Gottlieb warns of a looming health crisis due to the recently passed Inflation Reduction Act. With 130 drugs already in shortage, including vital cancer treatments, patients’ lives are at risk. The Act’s limitations on drug prices hinder generic manufacturers from recouping costs, leading to further shortages. Gottlieb emphasizes the critical shortage of sterile injectable drugs and exposes Big Pharma’s failure to reinvest in manufacturing facilities, resulting in quality issues. The crisis is exemplified by the extreme scarcity of Ozempic, a crucial diabetes treatment. This medical catastrophe demands immediate attention and action to protect patients.
Hollywood is once again engulfed in controversy as Melissa McCarthy fields a brazen question from…
Prince William, offering rare insight into Kate Middleton's ongoing cancer battle, has revealed the Duchess…
In this explosive special report, we delve into the shocking lawsuit filed by Georgia State…
In a chilling development straight out of a Terminator movie, DARPA has unveiled its latest…
Deion Sanders, legendary NFL star turned college football coach, finds himself at the center of…
Join Gary Franchi tonight as we delve into the explosive reaction from Whoopi Goldberg over…